Member Info for gammybaby

showing as a sell. Im in - going to tuck this away now GLA

Nearly bought in at 160 ish......but trying to now keep to a 3 day rule on stocks that drop.....This doesn't look good. Sorry for LTHs losses - appalling BOD - they need to be sacked. Ill keep an eye on here as may be worth picking up a few later on and placing for a long term hold. Good luck all.

I must admit - the share price haws been kept in a tight range today, despite more "sells"....news due.

In addition....when reading the original RNS - they didnt state it was statistically significant - they merely stated, that the complete study (not a trial, BUT a study) had a P value of 0.08.....(the area under the curve). They stated that there belief was that the study was finished and their belief was that steroids in there opinion had a Significant effect on the efficacy of Traumakine....which as a complete dossier, they were now taking to the FDA EMEA etc, to discuss the next phase iii trial. They would not be doing this without a real understanding of what was going on - which you obviously not, as you sold out at circa 60p. They would NOT be throwing 100s of thousands pounds more of there cash together with the millions already invested....without a real conviction about the product. Unfortunately, you not the expert here, and you lost a lot of money - thats a shame - but its time you got over it...and moved on Mani.

Really!????

The Yoda study, was a small study - just to look at the effects - which collaborates there earlier, extensive analysis. The whole reason of which, was to add support TO SHOW the FDA etc - so that they could then do a NEW phase iii trial. It was NOT in itself a trial - get real. It was a small study to add support to what they believed from the extensive analysis of the Interest study, to perhaps further show that steroids affect the affect of Traumakine. YOU were NOT agreeing with another poster - you were trying to rubbish the Yoda results, together with the other poster, in a rant that "THEY WERE NOT SIGNIFICANT" from a statistical point of view NO they were not at - but anyone with half an ounce of understanding statistical methods, would know that the number was too small (10 and 12 volunteers)...NO doubt...if it had come back with a p value of 0.01 or indeed 0.001 you would have been screaming from the roof tops that it wsnt valid, because the numbers were small..........AGAIN - get a grip...it wasnt a trial....it was to further aid in the understanding of the efficacy of traumakine had been hindered by steroids...which it did together with the earlier endothelial studies. Whatever, way you try to spin this negatively - it is clear that you are just a bitter person. Youre NOT invested here - so please just leave this board alone - you really do have a problem if you cant pull yourself together. GLA genuine HOLDERS!

YAWN>>>>>>>>>>>>>>>off you Trot. It was a small study......that was its design you really need to get a grip...now off you Trott!

It is brilliant. I think and hope that she will finally get over the fact that she has lost the potential for a near 200% rise on where she sold out (as well as far more in the coming months), and finally move away from constantly trolling this board! Its great news and confirms, what all us believers....believe. This will happen...and when it does, and Zenghy baby puts it - BOOM TIME!

GLA -- have a great day ;)

Hereith is a post i emailed to investigators last week, trying to ascertain, primarily for HER benefit, the reason of the figure of 0.08 being not statistically significant......ONCE again, as i stated - it was due to low sample.....either way, not far off 0.05.........but read and enjoy believers!...No wonder shes been quiet - iff shed had the gall to contact them herself.........which she either did not..or did and got the same response - so decided not to blab about it.....

Here it is!

Me:

"to investor.relations

Dear Sirs can you please clarify, how this study confirms previous analysis wit a p value of 0.08? Usually you would think that that is not statistically significant, especially with such a small cohort of patients? I await an urgent response.

Many thanks"

Response:- (which i received 2 minutes ago)

"to investor.relations

Dear Sirs can you please clarify, how this study confirms previous analysis wit a p value of 0.08? Usually you would think that that is not statistically significant, especially with such a small cohort of patients? I await your timely response"

Many thanks

Their reply :-

Dear Mr Xxxxxxxxx,

Many thanks for your email. We respond to queries on behalf of senior management at Faron.

While the results were not statistically significant – as you say, the patients numbers were very small – the Company believes they are consistent with the INTEREST data and support the earlier assumption that co-administration of steroids with Traumakine in patients inhibited IFN-beta action. The phase III Japanese Traumakine study, undertaken by Faron’s partner Maruishi, also supported this finding. And ex-vivo human lung studies have also shown that cortisone blocks completely INF-beta signalling pathways, an effect also seen in human primary lung endothelial cells.

As Markku Jalkanen, Faron’s Chief Executive Officer, said in Friday’s statement, the YODA report will now be used in discussions with regulators on the design and next steps for a further phase III trial of Traumakine in the treatment of ARDS.

Best wishes.





David Daley

Senior Associate Partner"
(from Consillium)




Im happy with that response - Onwards and upwards!

A month ago i was over 50% down(from mt initial investments last year)........NOW im around 60% overall up. I just mistimed it! Im looking forward to us all being rewarded in the not too distant future for believing in the company. I for one will not be selling anything until this is properly re-rated. I do honestly believe that this could go back to £8 in short order given some of the news expected. With a partner on board this could go mental. I hope for not just our sake, but those that could do with the drug (TK) get it sooner, rather than later. I think the result definitely should allow this to be used - if there was a preference by an individual or families to try it without steroids in cases of ARDS without full approval, based on the previous data from the lancet, and the supporting evidence from resent YODA trials as well as analysis of the previous phase 3 data. AIMHO....GLA - exciting times!

SORRY GUYS WRONG BOARD!

A month ago i was over 50% down(from mt initial investments last year)........NOW im around 60% overall up. I just mistimed it! Im looking forward to us all being rewarded in the not too distant future for believing in the company. I for one will not be selling anything until this is properly re-rated. I do honestly believe that this could go back to £8 in short order given some of the news expected. With a partner on board this could go mental. I hope for not just our sake, but those that could do with the drug (TK) get it sooner, rather than later. I think the result definitely should allow this to be used - if there was a preference by an individual or families to try it without steroids in cases of ARDS without full approval, based on the previous data from the lancet, and the supporting evidence from resent YODA trials as well as analysis of the previous phase 3 data. AIMHO....GLA - exciting times!

Lol

Now past 160!

Offer going to hit 160 any minute.

TOP OF THE RISERS BOARD ....AGAIN!!!!

It's name!

Already back to 155/158

This is going to go mental....We all know it apart from mani

The americans like biotechnology. ..still think we may finish above 160 today.....let's see.

Actually i think youll see its now going back up.......the bid to offer still showing 157 to 162.......they are making a market - please sell...youll help others buy in before its too late ;)